
    
      This is a prospective, multicenter, single arm and controlled clinical investigation compared
      to recent historical results. The purpose is to evaluate the safety, performance and efficacy
      of the VitaflowTM II Transcatheter Aortic Valve system.

      The entire system including valve system, delivery system and introducer system. We will
      implant the valve system into subjects and followed up them for 5 years after the procedure.
      This clinical trial will be conducted in 15 sites in Europe.
    
  